Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01727284 · ClinicalTrials.gov registry record · NA
MR-Guided Cryoablation of Prostate Bed Recurrences
A NA study of Prostate Tumors, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT01727284 is a NA study of Prostate Tumors that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 107 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01727284, a NA study of Prostate Tumors, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
Conditions Studied
Interventions
- PROCEDURE MR-guided cryoablation
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2012-12-12 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01727284
The ClinicalTrials.gov registry entry for NCT01727284 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Tumors appearing as the primary indexed condition, and to 1 intervention - of which MR-guided cryoablation is the first listed.
NCT01727284 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01727284 about?
NCT01727284 is a clinical study titled "MR-Guided Cryoablation of Prostate Bed Recurrences". The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
What is the current status of trial NCT01727284?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 107 participants. The study started on 2012-12-12. Estimated completion is 2026-11.
What conditions does trial NCT01727284 study?
This clinical trial studies the following conditions: Prostate Tumors.
What interventions are being tested in trial NCT01727284?
The interventions under investigation include: MR-guided cryoablation (PROCEDURE).
Who is sponsoring clinical trial NCT01727284?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01727284 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.